Clinical Trial Detail

NCT ID NCT02928406
Title A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements no
Sponsors Hoffmann-La Roche
Indications

urinary system cancer

Therapies

Atezolizumab

Age Groups: adult senior

No variant requirements are available.